We’re just about to the end of 2024, and it’s been an exciting year at VetStem. This year we were pleased to announce the commercial launch of our FDA-reviewed off-the-shelf PRP product, PrecisePRP. As we do every year, we’re wrapping up the VetStem blog with some highlights from the last 12 months. So, without further ado, here is VetStem’s 2024 year in review!

• In early 2024, we announced that VetStem reached a significant industry leading milestone. As of February, we had processed over 16,000 patient samples resulting in over 38,000 stem cell treatments.
• At the same time, two of our most prolific small animal users reached a milestone in stem cell cases. Drs. Jeff Christiansen and Kim Carlson both surpassed 300 cases. To date, Dr. Christiansen has performed 342 stem cell collections and Dr. Carlson has performed 326 – wow!
• In mid April, VetStem sponsored a lab at the annual IVAPM Pain Management Forum for the third year in a row. Veterinarians at this forum have a particular interest in multi-modal pain management and were excited to learn about PrecisePRP.
• Later in April, we were thrilled to announce that our latest platelet-rich plasma product, PrecisePRP Canine, had completed FDA review and officially became the first FDA-reviewed allogeneic off-the-shelf cell medicine product in the U.S.
• Shortly afterward, we announced the launch of PrecisePRP Equine, the second allogeneic cell medicine product to complete FDA-review.
• In May, the VetStem Sales and Marketing team was in Nashville where we sponsored and exhibited at the Fetch DVM360 Nashville veterinary conference. VetStem proponent and pain specialist Dr. Jamie Gaynor delivered two lectures about stem cell therapy and platelet-rich plasma.
• In July, we shared a fun update about a Sichuan Takin that received VetStem Cell Therapy for arthritis.
• August saw the VetStem Sales and Marketing team in Kansas City, MO for the annual Fetch DVM360 conference. We sponsored and exhibited at this show where our CEO, Dr. Bob  Harman, delivered two lectures about regenerative medicine.
• In October, we released updated efficacy data for PrecisePRP Canine. Out of 59 dogs who received PrecisePRP for orthopedic conditions, 47 of them showed significant improvement!
• Also in October, the Sales and Marketing team was back on the road at the Fetch Coastal veterinary conference in Atlantic City, NJ. VetStem proponent Dr. Alistair Chapnick delivered two lectures on stem cell therapy and PRP.
• In early December, the Sales and Marketing team wrapped up a busy year of conferences at the final Fetch DVM360 conference in Long Beach, CA. At this show, Drs. Bob Harman and Jamie Gaynor teamed up to deliver two lectures about comprehensive management of osteoarthritis and regenerative medicine.

So, there you have it. Another year in the books. It was an exciting year for us and, as always, we couldn’t do what we do without the support of our veterinary and pet owner clients. We hope that you and your loved ones have a wonderful holiday season, and we look forward to seeing what 2024 has in store for VetStem!

Last weekend, the VetStem Sales and Marketing team had the privilege of sponsoring, speaking, and exhibiting at the DVM360 Fetch Veterinary Conference in Long Beach, CA. Attending these veterinary conferences is always a fantastic opportunity for us to connect with both current and potential clients in person. At nearly every conference, we run into someone who has had their own pet treated with VetStem Cell Therapy. It’s always inspiring to hear their success stories firsthand!

At this year’s Fetch Long Beach event, our CEO, Dr. Bob Harman, co-presented with pain specialist and VetStem enthusiast, Dr. Jamie Gaynor. Their first lecture focused on a comprehensive approach to managing osteoarthritis. While stem cell therapy is a valuable option for pets with arthritis, many animals benefit from a multimodal treatment plan. The session explored the combination of traditional treatments like NSAIDs and physical rehabilitation with cutting-edge therapies, including CBD and regenerative medicine techniques like stem cell therapy and platelet-rich plasma (PRP). A holistic approach to canine osteoarthritis could lead to more effective outcomes.

In their second lecture, Drs. Harman and Gaynor discussed the broad range of conditions for which pets have received both VetStem Cell Therapy and PRP. While orthopedic conditions such as osteoarthritis and soft tissue injuries continue to be the primary use for stem cells, many pets have also received stem cell therapy for internal medicine conditions such as kidney disease, inflammatory bowel disease, and more! Likewise, PRP has been used for a number of years to manage conditions such as wound healing and corneal ulcers.

As we conclude the 2024 conference season, we want to express our gratitude to everyone who visited our booth and attended our presentations. We are excited to collaborate with many of you in the year ahead!

At VetStem, we are proud to support the veterinary community and celebrate the incredible contributions veterinarians make to animal health. International Day of Veterinary Medicine, observed on December 9^th, offers an important opportunity to recognize the dedication and expertise of veterinarians worldwide, who work tirelessly to improve the lives of animals and their owners. Whether it’s through routine care or advanced treatments, veterinary professionals are the unsung heroes who help keep our furry friends healthy and happy.

As pioneers in regenerative veterinary medicine, VetStem is committed to advancing the field with innovative stem cell therapies and cutting-edge technologies. We work alongside veterinarians to provide them with the tools and support they need to offer the best possible care for their patients. Our goal is to help veterinarians enhance their practice by providing options like stem cell therapy and platelet-rich plasma (PRP) for orthopedic conditions, in an effort to give animals a better quality of life.

As we approach International Day of Veterinary Medicine, we want to thank veterinarians and their staff for their unwavering passion and commitment to animal well-being. Their expertise not only saves lives but also creates lasting bonds between pets and their families. At VetStem, we look forward to continuing to partner with veterinary professionals to bring the best advancements in animal care to the forefront and ensure animals everywhere have access to these potentially life-saving treatments.